6,678 trials
Anemia
Primary: Percentage of Participants Maintaining Mean Hemoglobin Levels Within the Target Range During the Last 4 Weeks of the Treatment Period (Weeks 8 to 12) — 57.89 Percentage…
Essential Vocal Tremor · Essential Voice Tremor · Essential Tremor
Primary: Change in Quality of Life in Essential Tremor (QUEST) Questionnaire Score — 39.41; 29.50; 23.60 units on a scale
Total Joint Arthroplasty
Primary: Blood Transfusion — 5; 8; 1 participants
Dry Eye Syndromes
Primary: Change From Baseline in Total Corneal Staining Score With Fluorescein in the Worse Eye — 7.29; -1.96 Scores on a Scale
Non-Squamous Non-Small Cell Lung Cancer
Primary: Number of Participants With Adverse Events of Special Interest — 687; 672; 26; 30 participants
Adhesions · Cesarean Section · Delivery, Obstetric
Primary: Incidence of Adhesions — 75.6; 75.9 percentage of patients with adhesions
Airway Complication of Anaesthesia · Healthy
Primary: Upper Airway Closing Pressure — -9.83; -10.77 cm H20
Readiness to Discharge
Primary: The Primary Outcome is Time Until a Patient is "Ready for Discharge." — 3.2; 3.2 days
Attention Deficit Disorder With Hyperactivity
Primary: NCBRF-TIQ D-Total Score — 43.5; 42.1; 24.9; 25.9 units on a scale
Attention Deficit Hyperactivity Disorder (ADHD)
Primary: SKAMP-Combined Scores — 10.0; 17.8 units on a scale — p=<0.0001
Hepatitis C, Chronic
Primary: HCV RNA Profile During The First 24 Weeks — 6.50; 6.61; 6.55; 6.53 log 10 copies/mL
COPD
Primary: Forced Expiratory Volume in 1 Second (FEV1) AUC0-4h After First Dose of Treatment. — 1.7432; 1.7132 Liters*hours — p=0.0250
Oral Bacteria Levels in the Mouth
Primary: Anaerobic Bacteria — 8.40; 8.42; 8.43 colony forming units — p=>0.05
Type 2 Diabetes Mellitus
Primary: Myocardial Fat Content — 1.7; 1.1 percentage of myocardium content
Stable Angina · Coronary Disease
Primary: Number of Myocardial Ischemia Attacks in 24 Hours — 2.3; 3.8 ischemic attacks per 24 hours — p=<0.0001